How did we rapidly implement a convalescent plasma program?

Alexandra Budhai, Annie A Wu, Lucette Hall, Donna Strauss, Sarai Paradiso, Jill Alberigo, Christopher D Hillyer, Betsy Jett, Aaron A R Tobian, Evan M Bloch, Bruce S Sachais, Beth H Shaz

How did we rapidly implement a convalescent plasma program?

Authors:
Annie A Wu
Annie A Wu
The Johns Hopkins University School of Medicine
MD/PhD Candidate
Baltimore, MD | United States

Transfusion 2020 07 11;60(7):1348-1355. Epub 2020 Jun 11.

New York Blood Center Enterprises, New York, New York, USA.

Since the beginning of the COVID-19 pandemic, the use of convalescent plasma as a possible treatment has been explored. Here we describe our experience as the first U.S. organization creating a COVID-19 convalescent plasma program to support its use through the single-patient emergency investigational new drug, the National Expanded Access Program, and multiple randomized controlled trials. Within weeks, we were able to distribute more than 8000 products, scale up collections to more than 4000 units per week, meet hospital demand, and support randomized controlled trials to evaluate the efficacy of convalescent plasma treatment. This was through strategic planning; redeployment of staff; and active engagement of hospital, community, and public health partners. Our partners helped with donor recruitment, testing, patient advocacy, and patient availability. The program will continue to evolve as we learn more about optimizing the product. Remaining issues to be resolved are antibody titers, dose, and at what stage of disease to transfuse.

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.15910DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283779PMC
July 2020
3.225 Impact Factor

Publication Analysis

Top Keywords

convalescent plasma
16
plasma treatment
8
randomized controlled
8
controlled trials
8
strategic planning
4
treatment strategic
4
evaluate efficacy
4
planning redeployment
4
efficacy convalescent
4
active engagement
4
hospital community
4
community public
4
engagement hospital
4
trials evaluate
4
staff active
4
redeployment staff
4
demand support
4
products scale
4
8000 products
4
distribute 8000
4

References

(Supplied by CrossRef)
Convalescent plasma: new evidence for an old therapeutic tool?
Marano G et al.
Blood Transfus 2016

Similar Publications